intracellulartherapies.com (ITCI) Cash Funds per Share

Symbol and logo of brand Intra-Cellular (ITCI)

Intra-Cellular Therapies (ITCI) leads the development of neuropsychiatric drugs thanks to the success of Caplyta, although reliance on a single product and future competition from generics create certain risks. Assessing the cash position per share helps monitor business stability, while 9.41 captures the current value of this indicator. The company is currently at the peak of its reputation, benefiting from immense trust among psychiatrists.

intracellulartherapies.com (ITCI): Cash Funds per Share from 07/04/2022 to 04/13/2025

Analytical breakdowns for Intra-Cellular Therapies Inc. (ITCI)

- cash and cash flow data:
Summary company analysis:Intra-Cellular Therapies, Inc. - ITCI
Flagship merchandise of Intra-Cellular Therapies, Inc.

Investors must balance an asset's current yield against its liquidity risks. The trend in cash per share reflects the ratio of net cash to the number of shares, determining the financial stability of management. While a stable line precludes a funding deficit, it signals inefficient capital allocation. For Intra-Cellular Therapies (ITCI), this reserve is critical for maintaining the seamless distribution of drugs through pharmacy networks. Optimizing this balance ensures therapy availability without freezing resources.

Key competitors

Biogen Corp (BIIB) - Cash Funds Calculated per Share|Cash per Share NBIX|RGC - Cash on Hand per Share|Cash Funds per Share Axsome Therapeutics AXSM|Cash per Share ACADIA Pharmaceuticals Inc. ACAD|xenon-pharma.com - Cash per Share|Cash on Hand per Share Viking Therapeutics|SUPN: Cash per Share|Catalyst Pharmaceuticals (CPRX) - Cash per Share|Cash per Single Share DNLI|Cash Funds per Single Share HRMY (Harmony Biosciences Holdings, Inc.)|Cash Funds per Share Biohaven Ltd. (BHVN)|Cash Calculated per Single Share AMLX|Cash Funds per Share trevitherapeutics.com TRVI|PRAX - Cash per Single Share|Anavex Life Sciences Corp - Cash per Share|Cash on Hand per Share CeriBell Corp|Prothena Corporation PLC (PRTA) - Cash Funds per Share|Alector Therapeutics - Amount of Cash per Share|Cash Funds per Share Annexon Biosciences|Cash on Hand per Share omeros.com OMER|Cash Funds per Share Neurogene (NGNE)|Cash Funds Calculated per Share AC Immune S.A.|Cash per Share VYGR (Voyager Therapeutics Inc)|Amount of Cash per Share NMRA|scilexholding.com - Cash per Share|TVGN (tevogen.com) - Cash Funds per Single Share|ACOG: Cash per Share|CGTX: Cash Calculated per Single Share|Cash Funds per Share Inhibikase Therapeutics|Cash Funds per Single Share SAVA (Cassava)|Cash Funds per Share Assertio Therapeutics (ASRT)|Coya Therapeutics - Cash Funds per Single Share|VistaGen Therapeutics, Inc. - Cash per Single Share|ovidrx.com (OVID) - Cash on Hand per Share|ABOS: Cash per Single Share|Cash on Hand per Share CervoMed Inc|alteritytherapeutics.com (ATHE) - Cash Funds per Share|Cash per Single Share Clene Nanomedicine|Cash per Single Share PEPG|Cash on Hand per Share Jupiter Neurosciences JUNS|Cash Funds per Share Relmada (RLMD)|Cash Funds Calculated per Share Annovis Bio, Inc.|Cash per Share GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Cash on Hand per Share|KLTO - Cash Funds per Share|Cash on Hand per Share NeuroSense Therapeutics Ltd|RVPH: Cash per Share|MetaVia, Inc. (MTVA) - Cash per Share|Cash Funds per Share NeurAxis|Cash per Share heliusmedical.com|Cash per Single Share PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Cash Funds per Single Share|Minerva Neurosciences Corp - Cash per Single Share|Amount of Cash per Share ATHA|ADXN - Cash Funds per Share|Cash on Hand per Share Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Cash Funds per Share|Cash Funds per Single Share PTIX|KTTA (pasitheaclinics.com) - Cash per Share|CRGT (cortigent.com) - Cash Calculated per Single Share|Cash per Share ATXI|Cash Funds per Share BCLI (Brainstorm Cell)|Cash per Share CARA (Cara Therapeutics Inc)|Amount of Cash per Share CHRO|Eliem Therapeutics Inc. - Cash per Share|Amount of Cash per Share LBPH (Longboard)|marinuspharma.com (MRNS) - Cash Funds per Share|NKGN - Cash Funds Calculated per Share|NRBO (neurobopharma.com) - Cash per Share|Sage Therapeutics (SAGE) - Cash Funds Calculated per Share|Cash per Single Share SNPX (Synaptogenix, Inc.)|TRVN - Cash on Hand per Share|Cash per Share VIGL (Vigil Neuro)|WENA: Cash Funds per Single Share|CERE - Cash Funds per Share